These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36852660)

  • 21. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.
    Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ
    PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor.
    Muñoz-Bello JO; Olmedo-Nieva L; Castro-Muñoz LJ; Manzo-Merino J; Contreras-Paredes A; González-Espinosa C; López-Saavedra A; Lizano M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells.
    Wei Q
    J Biol Chem; 2005 Nov; 280(45):37790-7. PubMed ID: 16129685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
    Li W; Anderson RA
    Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.
    Tomaic V; Pim D; Thomas M; Massimi P; Myers MP; Banks L
    J Virol; 2011 Apr; 85(7):3120-7. PubMed ID: 21228227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
    Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV-18E6 Inhibits Interactions between TANC2 and SNX27 in a PBM-Dependent Manner and Promotes Increased Cell Proliferation.
    Broniarczyk JK; Massimi P; Trejo-Cerro O; Myers MP; Banks L
    J Virol; 2022 Nov; 96(22):e0136522. PubMed ID: 36326272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.
    Shai A; Pitot HC; Lambert PF
    Cancer Res; 2010 Jun; 70(12):5064-73. PubMed ID: 20530688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
    Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
    J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between E6AP and E6 proteins from alpha and beta HPV types.
    Thomas M; Tomaić V; Pim D; Myers MP; Tommasino M; Banks L
    Virology; 2013 Jan; 435(2):357-62. PubMed ID: 23206439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.
    Brimer N; Lyons C; Vande Pol SB
    Virology; 2007 Feb; 358(2):303-10. PubMed ID: 17023019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of E6AP-independent degradation targets of HPV E6.
    Vats A; Thatte J; Banks L
    J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
    Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
    PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.